| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/09/2003 | CN1408357A Powder medicine suitable for human and animal trauma |
| 04/09/2003 | CN1408350A Medicine for curing burn and scald and its preparing method |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105101C Beta-sultonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/09/2003 | CN1104906C Tibetan-medicinal bath for treating rheumatism and its preparing process |
| 04/09/2003 | CN1104905C Novel powder compositions |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/09/2003 | CN1104896C RAR-gamma antagonist ligand or RAR-alpha agonist ligand as apoptosis inhibitor |
| 04/09/2003 | CN1104889C Skin care compositions containing amide and retinoid |
| 04/08/2003 | WO2002034715A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545030 1-heterocycle substituted diarylamines |
| 04/08/2003 | US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane |
| 04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
| 04/08/2003 | US6545013 2,7-naphthyridine derivatives |
| 04/08/2003 | US6545005 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/08/2003 | US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/08/2003 | US6544998 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 04/08/2003 | US6544993 Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors |
| 04/08/2003 | US6544991 Compositions and methods for treating bacterial infections |
| 04/08/2003 | US6544988 Tyrosine kinase inhibitors |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/08/2003 | US6544969 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin D compounds |
| 04/08/2003 | US6544963 Alkali metal or alkali earth metal salt of carboxylmethyl cellulose, and a carrier; promoting cellular adhesion, wound healing, controlling bleeding |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544541 Devices and compounds for treating arterial restenosis |
| 04/08/2003 | US6544533 10-hydroxy-2-decenoic acid compounds for promoting desquamation/epidermal renewal of the skin and/or combating skin aging |
| 04/08/2003 | US6544499 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care |
| 04/08/2003 | CA2232583C Lipoic acid in topical compositions |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2048243C 4-amino- 4,6-steroids and their use as 5-.alpha.-reductase inhibitors |
| 04/08/2003 | CA2023810C Pharmaceutical composition |
| 04/07/2003 | WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 04/03/2003 | WO2003027285A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027234A2 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | WO2003027232A2 Method for producing biologically active products |
| 04/03/2003 | WO2003027154A1 Polymers with structure-defined functions |
| 04/03/2003 | WO2003027116A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 04/03/2003 | WO2003027115A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 04/03/2003 | WO2003027111A1 Chemical compounds |
| 04/03/2003 | WO2003027108A1 Heterocyclic derivatives and their use as hypoglycaemic and hypolipidemic agents |
| 04/03/2003 | WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003027090A2 Bicyclic heterocycles as rxr ligands |
| 04/03/2003 | WO2003027089A1 Benzofuran, indole or benzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/03/2003 | WO2003027080A1 3-substituted-4-pyrimidone derivatives |
| 04/03/2003 | WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 04/03/2003 | WO2003026698A1 External preparation for the skin |
| 04/03/2003 | WO2003026680A2 Method and topical formulation for treating skin conditions associated with aging |
| 04/03/2003 | WO2003026673A1 Modulation of vitamin storage |
| 04/03/2003 | WO2003026663A1 Process for making substituted pyrazoles |
| 04/03/2003 | WO2003026660A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 04/03/2003 | WO2003026658A1 Method for the treatment or prevention of atopic dermatitis |
| 04/03/2003 | WO2003026643A2 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| 04/03/2003 | WO2003026640A1 Treating food allergies and/or food intolerances |
| 04/03/2003 | WO2003026638A1 Neuroprotective treatment methods using selective inos inhibitors |
| 04/03/2003 | WO2003026606A1 Compositions for improving skin barrier function |
| 04/03/2003 | WO2003026604A1 Anti-inflammatory dermocosmetologic composition in particular for treating acne and seborrheic dermatitis |
| 04/03/2003 | WO2003026602A2 Medicine for preventing and treating bromidrosis |
| 04/03/2003 | WO2003026579A2 Combination therapies for immune mediated diseases |
| 04/03/2003 | WO2003026568A2 Androstanes as androgen receptor modulators |
| 04/03/2003 | WO2003026430A1 Treatment of allergic rhinitis |
| 04/03/2003 | WO2003006104A3 Lymphatic endothelial cells materials and methods |
| 04/03/2003 | WO2003002722A3 T cell regulatory genes and methods of use thereof |
| 04/03/2003 | WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 04/03/2003 | WO2002100332A3 Isoxazoline compounds having mif antagonist activity |
| 04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 04/03/2003 | WO2002070559A3 Nuclear hormone receptor ligand binding domains |
| 04/03/2003 | WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES |
| 04/03/2003 | WO2002043731B1 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 04/03/2003 | WO2002022166A9 Tweak receptor agonists as anti-angiogenic agents |
| 04/03/2003 | WO2002018544A9 Method and reagents for treatment of skin disorders by modulating the notch pathway |
| 04/03/2003 | WO2002014369A9 Human kininogen d5 domain polypeptides and their use |
| 04/03/2003 | WO2002011698A9 Novel compositions of minoxidil |
| 04/03/2003 | WO2002000860A3 Novel proteases |
| 04/03/2003 | US20030065229 Bactericides; oxidation resistance; antiinflammatory agents; antitumor agents |
| 04/03/2003 | US20030065174 Antiinflammatory agents; analgesics |
| 04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
| 04/03/2003 | US20030065027 Compositions for controlling microorganisms, comprising primary and secondary esters of polyglycerol in an effective ratio |
| 04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
| 04/03/2003 | US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/03/2003 | US20030065007 Analgesics; psychological disorders; antidepressants |
| 04/03/2003 | US20030065004 Androgen receptor modulators and methods for use thereof |
| 04/03/2003 | US20030064996 Anticarcinogenic agents, antiinflammatory agents, anticholesterol agents, antidiabetic agents |
| 04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/03/2003 | US20030064987 Immunology moderators; interleukin antagonist; anticancer agents |
| 04/03/2003 | US20030064959 Mixture with polyacrylic acid and xanthan gumo |
| 04/03/2003 | US20030064958 Pharmaceutical compositions and methods relating to fucans |
| 04/03/2003 | US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 04/03/2003 | US20030064935 Amino acid complexes of C-aryl glucosides for treatment of diabetes and method |
| 04/03/2003 | US20030064929 Modulating body/cranial hair growth |
| 04/03/2003 | US20030064927 Regeneration of soft tissue; wound healing agents |
| 04/03/2003 | US20030064475 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/03/2003 | US20030064369 Novel proteins and nucleic acids encoding same |
| 04/03/2003 | US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/03/2003 | US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents |